KMI vs MAIA · P/E 24, rev $9.30B vs $56.9M cap
Kinder Morgan Inc (KMI) versus MAIA Biotechnology Inc. (MAIA) — a side-by-side from cached financials, not a winner call.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
MAIA Biotechnology Inc. (MAIA) is a biotechnology company listed on US.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Latest reported MAIA revenue for 2024-12-31 was $0. Net income was -$23.3M. MAIA currently screens at market cap $56.9M.
KMI currently screens at market cap $62.53B and trailing P/E 24.2. MAIA currently screens at market cap $56.9M.
Not investment advice. Open the KMI and MAIA stock pages for the full models.
Not investment advice.